Inventor
MANIAR MANOJ
US20 patents
⚠️ This page may combine multiple inventors who share the name “MANIAR MANOJ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVA PHARM CORP
5 patentsUS5227165AJul 13, 1993
Liposphere delivery systems for local anesthetics
NOVA PHARM CORP176 citations99
US5240963AAug 31, 1993
Branched polyanhydrides
NOVA PHARM CORP50 citations96
US5175235ADec 29, 1992
Branched polyanhydrides
NOVA PHARM CORP82 citations96
US5317079AMay 31, 1994
Fatty acid terminated polyanhydride
NOVA PHARM CORP27 citations92
US5179189AJan 12, 1993
Fatty acid terminated polyanhydrides
NOVA PHARM CORP41 citations92
MANIAR MANOJ
4 patentsUS8476320B2Jul 2, 2013
Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones
MANIAR MANOJ17 citations82
US8889736B2Nov 18, 2014
Formulations for the treatment of pain
MANIAR MANOJ2 citations61
US9060967B2Jun 23, 2015
Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone
MANIAR MANOJ1 citations51
US11583552B2Feb 21, 2023
Pharmaceutical formulation of arsenic trioxide
MANIAR MANOJ0 citations50
ONCONOVA THERAPEUTICS INC
4 patentsUS10098862B1Oct 16, 2018
Formulations with enhanced stability and bioavailability for administration of (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones
ONCONOVA THERAPEUTICS INC2 citations72
US11382877B2Jul 12, 2022
Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability
ONCONOVA THERAPEUTICS INC1 citations62
US10576050B2Mar 3, 2020
Methods and compositions for treatment of cancer
ONCONOVA THERAPEUTICS INC1 citations52
US9713597B2Jul 25, 2017
Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone
ONCONOVA THERAPEUTICS INC0 citations51